文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

水飞蓟(水飞蓟属植物)用于肝病治疗。

Milk thistle (Silybum marianum) for the therapy of liver disease.

作者信息

Flora K, Hahn M, Rosen H, Benner K

机构信息

Division of Gastroenterology, Oregon Health Sciences University, Portland 97201-3098, USA.

出版信息

Am J Gastroenterol. 1998 Feb;93(2):139-43. doi: 10.1111/j.1572-0241.1998.00139.x.


DOI:10.1111/j.1572-0241.1998.00139.x
PMID:9468229
Abstract

Silymarin, derived from the milk thistle plant, Silybum marianum, has been used for centuries as a natural remedy for diseases of the liver and biliary tract. As interest in alternative therapy has emerged in the United States, gastroenterologists have encountered increasing numbers of patients taking silymarin with little understanding of its purported properties. Silymarin and its active constituent, silybin, have been reported to work as antioxidants scavenging free radicals and inhibiting lipid peroxidation. Studies also suggest that they protect against genomic injury, increase hepatocyte protein synthesis, decrease the activity of tumor promoters, stabilize mast cells, chelate iron, and slow calcium metabolism. In this article we review silymarin's history, pharmacology, and properties, and the clinical trials pertaining to patients with acute and chronic liver disease.

摘要

水飞蓟素源自水飞蓟植物(Silybum marianum),几个世纪以来一直被用作治疗肝脏和胆道疾病的天然药物。随着美国对替代疗法的兴趣日益浓厚,胃肠病学家遇到越来越多服用水飞蓟素的患者,而他们对其所谓的特性了解甚少。据报道,水飞蓟素及其活性成分水飞蓟宾具有抗氧化作用,可清除自由基并抑制脂质过氧化。研究还表明,它们可防止基因组损伤、增加肝细胞蛋白质合成、降低肿瘤启动子的活性、稳定肥大细胞、螯合铁并减缓钙代谢。在本文中,我们回顾了水飞蓟素的历史、药理学、特性以及与急慢性肝病患者相关的临床试验。

相似文献

[1]
Milk thistle (Silybum marianum) for the therapy of liver disease.

Am J Gastroenterol. 1998-2

[2]
Milk thistle in liver diseases: past, present, future.

Phytother Res. 2010-10

[3]
A review of plants used in the treatment of liver disease: part 1.

Altern Med Rev. 1998-12

[4]
A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).

Altern Med Rev. 2005-9

[5]
Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).

Integr Cancer Ther. 2007-6

[6]
Advances in the use of milk thistle (Silybum marianum).

Integr Cancer Ther. 2007-6

[7]
Milk thistle.

Am Fam Physician. 2005-10-1

[8]
Milk thistle and chronic liver disease.

Hepatology. 2005-7

[9]
[Biologically active additive from milk thistle in the solution of public health problems].

Vopr Pitan. 1998

[10]
[Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies].

Clin Ter. 1980-8-15

引用本文的文献

[1]
Harnessing the Hepatoprotective and Nephroprotective Potential of Fractions via per os Administration in CCl-Intoxicated Wistar Rats: A Mixed Approach.

Pharmaceuticals (Basel). 2025-8-1

[2]
Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury.

BMC Complement Med Ther. 2025-4-12

[3]
Unraveling the metabolic activities of bioactive compounds on cellular models of hepatosteatosis and adipogenesis through docking analysis with PPARs.

Sci Rep. 2024-11-15

[4]
Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities.

Front Pharmacol. 2024-10-24

[5]
Exploring the antioxidant and protective effects of Hook.f. leaf extract against carbon tetrachloride-induced hepatic damage in rat models.

Front Pharmacol. 2024-10-22

[6]
A review of the botany, phytochemistry, pharmacology, synthetic biology and comprehensive utilization of .

Front Pharmacol. 2024-7-11

[7]
Chromosome-level genome assembly of milk thistle (Silybum marianum (L.) Gaertn.).

Sci Data. 2024-4-5

[8]
Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.

Can Liver J. 2024-2-26

[9]
Metabolic profiling of milk thistle different organs using UPLC-TQD-MS/MS coupled to multivariate analysis in relation to their selective antiviral potential.

BMC Complement Med Ther. 2024-3-7

[10]
Evaluation of the Effect of L. on the Liver Enzymes in Burn Patients: A Randomized Double-Blind Clinical Trial.

Int J Clin Pract. 2024

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索